Allogene Therapeutics, Inc. (ALLO) ownership: Top institutional holder: Pfizer Inc ($49.79M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Pfizer Inc | 22032040.00 | $49.79M | 2026-03-31 |
| BlackRock, Inc. | 19091095.00 | $46.58M | 2026-03-31 |
| TPG GP A, LLC | 18716306.00 | $45.67M | 2026-03-31 |
| STATE STREET CORP | 8660306.00 | $21.13M | 2026-03-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 8379840.00 | $20.45M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6921350.00 | $16.89M | 2026-03-31 |
| CITADEL ADVISORS LLC | 6793620.00 | $16.58M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 5375456.00 | $13.12M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-21 | |
| Sell | null | 2026-04-21 | |
| Sell | null | 2026-03-31 | |
| Sell | null | 2026-03-31 | |
| Sell | null | 2026-03-16 | |
| Sell | null | 2026-03-16 | |
| Sell | null | 2026-03-16 | |
| Sell | null | 2026-03-16 |
Back to ALLO overview · ALLO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.